QQ客服 官方微博 反馈留言

浏览/检索结果: 共15条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A single-arm, multicenter, phase 2 study of camrelizumab in relapsed or refractory classical Hodgkin lymphoma 期刊论文 2019 作者:  Song Yuqin;  Wu Jianqiu;  Chen Xinchuan;  Lin Tong-Yu;  Cao Junning 收藏  |  浏览/下载：26/0  |  提交时间：2020/01/03 The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients 期刊论文 2019, 卷号: 63, 页码: 59-65 作者:  Wu, Jianqiu;  Tang, Weiyan;  Huang, Laiquan;  Hou, Ning;  Wu, Jing 收藏  |  浏览/下载：18/0  |  提交时间：2020/01/03 Lymphoma  Cell-free DNA  ROC curve  Quantitative PCR   Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文 2019, 卷号: 14, 期号: 5, 页码: 867-875 作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie 收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03 Chinese population  Nivolumab  NSCLC  Phase III clinical study   Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial 期刊论文 2019, 卷号: 39, 期号: 1, 页码: 16 作者:  Huang, Jing;  Xu, Binghe;  Liu, Ying;  Huang, Junxing;  Lu, Ping 收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03 Esophageal squamous cell carcinoma  Recurrent  Metastasis  Multicenter  open-label  randomized trial  Irinotecan  S-1  Overall survival  Progression-free survival  Objective response rate  Disease control rate   Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 期刊论文 2018, 卷号: 78, 期号: 13 作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文 LABORATORY INVESTIGATION, 2018-03-01 作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng 收藏  |  浏览/下载：20/0  |  提交时间：2020/01/03 Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文 CANCER RESEARCH, 2018-07-01 作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 The age variation of HER2 immunohistochemistry positive rate in gastric cancer 期刊论文 2018, 卷号: 98, 页码: 311-312 作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03 BRAIN: A Phase III Trial Comparing WBI and Chemotherapy with Icotinib in NSCLC with Brain Metastases Harboring EGFR Mutations (CTONG 1201) 期刊论文 2017, 卷号: 12, 期号: 1, 页码: S6-S6 作者:  Wu, Yi Long;  Yang, Jin-Ji;  Zhou, Caicun;  Feng, Jifeng;  Lu, Shun 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 phase 3 trial  WBI  Brain metastasis  EGFR TKI   China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version) 期刊论文 2017, 卷号: 13, 期号: 1, 页码: 87-103 作者:  Shi, Yuankai;  Sun, Yan;  Yu, Jinming;  Ding, Cuimin;  Wang, Ziping 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/04